Antiretroviral treatment of HIV infected adults

被引:39
作者
Deeks, Steven G. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94110 USA
[2] San Francisco Gen Hosp, San Francisco, CA 94110 USA
来源
BMJ-BRITISH MEDICAL JOURNAL | 2006年 / 332卷 / 7556期
关键词
RECOMMENDATIONS; LAMIVUDINE; THERAPY; ZIDOVUDINE; EFAVIRENZ; INDINAVIR; DISEASE;
D O I
10.1136/bmj.332.7556.1489
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1489 / 1493
页数:5
相关论文
共 25 条
[1]   Fat distribution in men with HIV infection [J].
Bacchetti, P ;
Gripshover, B ;
Grunfeld, C ;
Heymsfield, S ;
McCreath, H ;
Osmond, D ;
Saag, M ;
Scherzer, R ;
Shlipak, M ;
Tien, P .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (02) :121-131
[2]  
Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55
[3]   Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy - A randomized trial [J].
Carr, A ;
Workman, C ;
Smith, DE ;
Hoy, J ;
Hudson, J ;
Doong, N ;
Martin, A ;
Amin, J ;
Freund, J ;
Law, M ;
Cooper, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02) :207-215
[4]   Adverse effects of antiretroviral therapy [J].
Carr, A ;
Cooper, DA .
LANCET, 2000, 356 (9239) :1423-1430
[5]  
Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195
[6]   Treatment of anti retroviral-drug-resistant HIV-1 infection [J].
Deeks, SG .
LANCET, 2003, 362 (9400) :2002-2011
[7]  
*DHHS, 2006, GUID US ANT AG HIV I
[8]   Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].
Egger, M ;
May, M ;
Chêne, G ;
Phillips, AN ;
Ledergerber, B ;
Dabis, F ;
Costagliola, D ;
Monforte, AD ;
de Wolf, F ;
Reiss, P ;
Lundgren, JD ;
Justice, AC ;
Staszewski, S ;
Leport, C ;
Hogg, RS ;
Sabin, CA ;
Gill, MJ ;
Salzberger, B ;
Sterne, JAC .
LANCET, 2002, 360 (9327) :119-129
[9]   Immune restoration disease after antiretroviral therapy [J].
French, MA ;
Price, P ;
Stone, SF .
AIDS, 2004, 18 (12) :1615-1627
[10]   Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV [J].
Gallant, JE ;
DeJesus, E ;
Arribas, JR ;
Pozniak, AL ;
Gazzard, B ;
Campo, RE ;
Lu, B ;
McColl, D ;
Chuck, S ;
Enejosa, J ;
Toole, JJ ;
Cheng, AK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (03) :251-260